Other

Dataset Information

0

Saturation genome editing of 11 codons and exon 13 of BRCA2 determines pathogenicity of variants


ABSTRACT: The pathogenicity of majority of variants identified in cancer-causing genes is unknown due to limited epidemiological data, hence they are considered to be variant of uncertain significance (VUS). To date, Breast Cancer gene-2 (BRCA2) has the highest number of VUSs, which has necessitated the development of several robust functional assays to determine their functional significance. Here we report the use of a humanized-mouse embryonic stem cell (mESC) line expressing a single copy of the human BRCA2 for a CRISPR-Cas9-based high-throughput functional assay. As a proof-of-principle, we have saturated 11 codons encoded by BRCA2 exons 3, 18, 19 and all possible single-nucleotide variants in exon 13 and multiplexed these variants for their functional categorization. Specifically, we used a pool of 180-mer single-stranded donor DNA to generate all possible combination of variants. Using a high throughput sequencing-based approach, we show a significant drop in the frequency of non-functional variants, whereas functional variants are enriched in the pool of the cells. We further demonstrate that variants with partial loss of BRCA2 function are sensitive to the DNA-damaging agents, cisplatin and olaparib, allowing us to discriminate between functional and intermediate variants. We have categorized 599 BRCA2 variants including 93-single nucleotide variants (SNVs) across the 11 codons, of which 28 are reported in ClinVar. We also functionally categorized 252 SNVs from exon 13 into 188 functional, 60 non-functional and 4 intermediate variants, demonstrating that saturation genome editing (SGE) coupled with drug sensitivity assays can enhance functional annotation of BRCA2 VUS.

ORGANISM(S): Mus musculus

PROVIDER: GSE238143 | GEO | 2023/08/30

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-09-27 | GSE248438 | GEO
2024-09-30 | GSE270424 | GEO
2023-11-20 | GSE244578 | GEO
2021-06-23 | GSE178646 | GEO
2023-06-12 | GSE234482 | GEO
2022-08-06 | GSE210602 | GEO
2022-02-01 | GSE182448 | GEO
2022-02-01 | GSE182449 | GEO
2023-07-20 | PXD034007 | Pride
2023-12-31 | GSE233683 | GEO